StockData
Curis Inc logo

Curis Inc (CRIS) stock

CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3091% below fair value
$0.61+0.07 (+13.38%)

Close on Nov 18, 2026Market cap $1.28MP/E –Yield –

Curis free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Curis's free cash flow for the twelve months ending Dec 31, 2023 was -$38.43M. For fiscal 2023 it was -$38.43M. The highest annual figure on record is -$1.90M in fiscal 2010.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$38.43M–
FY2022Dec 31, 2022-$54.75M–
FY2021Dec 31, 2021-$37.62M–
FY2020Dec 31, 2020-$26.42M–
FY2019Dec 31, 2019-$26.25M–
FY2018Dec 31, 2018-$30.15M–
FY2017Dec 31, 2017-$48.54M–
FY2016Dec 31, 2016-$36.14M–
FY2015Dec 31, 2015-$29.94M–
FY2014Dec 31, 2014-$16.91M–
FY2013Dec 31, 2013-$9.69M–
FY2012Dec 31, 2012-$15.30M–
FY2011Dec 31, 2011-$4.82M–
FY2010Dec 31, 2010-$1.90M–
FY2009Dec 31, 2009-$7.61M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$10.19M–
Q3 FY2023Sep 30, 2023-$8.18M–
Q2 FY2023Jun 30, 2023-$7.87M–
Q1 FY2023Mar 31, 2023-$12.20M–
Q4 FY2022Dec 31, 2022-$12.27M–
Q3 FY2022Sep 30, 2022-$13.17M–
Q2 FY2022Jun 30, 2022-$12.49M–
Q1 FY2022Mar 31, 2022-$16.83M–
Q4 FY2021Dec 31, 2021-$8.17M–
Q3 FY2021Sep 30, 2021-$9.61M–
Q2 FY2021Jun 30, 2021-$6.66M–
Q1 FY2021Mar 31, 2021-$13.18M–
Q4 FY2020Dec 31, 2020-$5.74M–
Q3 FY2020Sep 30, 2020-$6.04M–
Q2 FY2020Jun 30, 2020-$5.39M–
Q1 FY2020Mar 31, 2020-$9.26M–
Q4 FY2019Dec 31, 2019-$5.60M–
Q3 FY2019Sep 30, 2019-$6.70M–
Q2 FY2019Jun 30, 2019-$6.71M–
Q1 FY2019Mar 31, 2019-$7.23M–
Q4 FY2018Dec 31, 2018-$4.94M–
Q3 FY2018Sep 30, 2018-$8.23M–
Q2 FY2018Jun 30, 2018-$6.94M–
Q1 FY2018Mar 31, 2018-$10.04M–
Q4 FY2017Dec 31, 2017-$7.55M–
Q3 FY2017Sep 30, 2017-$16.50M–
Q2 FY2017Jun 30, 2017-$9.30M–
Q1 FY2017Mar 31, 2017-$15.20M–
Q4 FY2016Dec 31, 2016-$9.45M–
Q3 FY2016Sep 30, 2016-$7.60M–

More Curis figures

See a number that looks wrong?